STEPHEN CARL PFLUGFELDER
Medical Practice in Miami, FL
License number
Pennsylvania MD028015E
Category
Medicine
Type
Medical Physician and Surgeon
Address
Address
2
Miami, FL 33156
Pennsylvania
Pennsylvania
Personal information
See more information about STEPHEN CARL PFLUGFELDER at radaris.comName
Address
Phone
1201 Fitzwater St UNIT 105, Philadelphia, PA 19147
2027 Wharton Rd, Glenside, PA 19038
9945 57Th Ct, Miami, FL 33156
125 Sparks St, Philadelphia, PA 19120
2027 Wharton, Abington, PA 19001
Professional information
Method For Treating Meibomian Gland Disease
US Patent:
6455583, Sep 24, 2002
Filed:
May 7, 1999
Appl. No.:
09/307182
Inventors:
Stephen C. Pflugfelder - Miami FL
Balakrishna L. Lokeshwar - Miami FL
Marie Selzer - Fort Lauderdale FL
Balakrishna L. Lokeshwar - Miami FL
Marie Selzer - Fort Lauderdale FL
Assignee:
The University of Miami - Miami FL
International Classification:
A01N 3734
US Classification:
514528, 514912
Abstract:
A method for treating a patient having meibomian gland disease, ocular irritation associated with delayed tear clearance, or recurrent corneal epithelial erosion, is disclosed. Preferably, the method concerns treatment of a patient with topical tetracycline, a derivative or analogue of tetracycline, or a chemically modified tetracycline (CMT). Oral administration of a CMT is also disclosed as part of the method for treating meibomian gland disease, ocular irritation associated with delayed tear clearance, or recurrent corneal epithelial erosion.
Process And Device For Measuring Tear Fluorescein Clearance
US Patent:
6438398, Aug 20, 2002
Filed:
Mar 3, 2000
Appl. No.:
09/518693
Inventors:
Stephen C. Pflugfelder - Miami FL
Scheffer C. G. Tseng - Miami FL
Adolfo Afonso - Miami FL
Angelo Macri - Genova, IT
Scheffer C. G. Tseng - Miami FL
Adolfo Afonso - Miami FL
Angelo Macri - Genova, IT
Assignee:
The University of Miami - Miami FL
International Classification:
A61B 500
US Classification:
600321
Abstract:
A method of evaluating clearance of fluorescein dye instilled into tear film having a greater sensitivity and specificity for diagnosing a tear film disorder as the cause of a patients ocular irritation and ocular surface disease than can be achieved using the traditional methods. The inventive method can be performed using a diagnostic kit for evaluating tear fluorescence clearance in which the concentration of tear fluorescein is visually quantified via a color standard.
Non-Preserved Topical Corticosteroid For Treatment Of Dry Eye, Filamentary Keratitis, And Delayed Tear Clearance (Or Turnover)
US Patent:
6153607, Nov 28, 2000
Filed:
Dec 4, 1996
Appl. No.:
8/754060
Inventors:
Stephen C. Pflugfelder - Miami FL
Scheffer C. G. Tseng - Miami FL
Andrew J. W. Huang - Miami FL
Scheffer C. G. Tseng - Miami FL
Andrew J. W. Huang - Miami FL
Assignee:
University of Miami - Miami FL
International Classification:
A67K 3156
US Classification:
514178
Abstract:
A preservative-free composition containing an effective amount of a corticosteroid in an aqueous carrier to treat a dry eye condition. The composition may be provided as a part of a therapeutic regimen to treat a variety of dry eye conditions and ocular surface disorders manifesting delayed tear clearance previously not readily treatable. The composition may be packaged as containers of single dosage amounts of the corticosteroid-aqueous composition sufficient for pulsed-therapy of acute exacerbations of the irritation symptoms and ocular surface disease of conditions associated with dry eye and delayed tear clearance.
Use Of Secretory Products Of Human Lacrimal Gland Acinar Epithelia For Tear Replacement Therapy
US Patent:
5652209, Jul 29, 1997
Filed:
Apr 29, 1994
Appl. No.:
8/235673
Inventors:
Stephen C. Pflugfelder - Miami FL
Kenichi Yoshino - Miami FL
Scheffer C. G. Tseng - Miami FL
Andrew J. W. Huang - Miami FL
Kenichi Yoshino - Miami FL
Scheffer C. G. Tseng - Miami FL
Andrew J. W. Huang - Miami FL
Assignee:
University of Miami - Miami FL
International Classification:
A61K 3818
US Classification:
514 2
Abstract:
The present invention relates to medicinal compositions and more particularly refers to such compositions for tear replacement therapy having products of human lacrimal gland acinar epithelia, and more specifically, growth factors or cytokines, in particular, the transforming growth factor beta (TGF. beta. ).
Method For Treating Meibomian Gland Disease
US Patent:
2003011, Jun 19, 2003
Filed:
Aug 22, 2002
Appl. No.:
10/225341
Inventors:
Stephen Pflugfelder - Miami FL, US
Balakrishna Lokeshwar - Miami FL, US
Marie Selzer - Fort Lauderdale FL, US
Balakrishna Lokeshwar - Miami FL, US
Marie Selzer - Fort Lauderdale FL, US
International Classification:
A61K031/65
US Classification:
514/152000
Abstract:
A method for treating a patient having meibomian gland disease, ocular irritation associated with delayed tear clearance, or recurrent corneal epithelial erosion, is disclosed. Preferably, the method concerns treatment of a patient with topical tetracycline, a derivative or analogue of tetracycline, or a chemically modified tetracycline (CMT). Oral administration of a CMT is also disclosed as part of the method for treating meibomian gland disease, ocular irritation associated with delayed tear clearance, or recurrent corneal epithelial erosion.
Method For Treating Meibomian Gland Disease
US Patent:
2012008, Apr 12, 2012
Filed:
Dec 1, 2011
Appl. No.:
13/309145
Inventors:
Stephen C. Pflugfelder - Miami FL, US
Balakrishna L. Lokeshwar - Miami FL, US
Marie Selzer - Fort Lauderdale FL, US
Balakrishna L. Lokeshwar - Miami FL, US
Marie Selzer - Fort Lauderdale FL, US
Assignee:
THE UNIVERSITY OF MIAMI - Miami FL
International Classification:
A61K 31/65, A61P 31/00, A61P 27/02
US Classification:
514152
Abstract:
A method for treating a patient having meibomian gland disease, ocular irritation associated with delayed tear clearance, or recurrent corneal epithelial erosion, is disclosed. Preferably, the method concerns treatment of a patient with topical tetracycline, a derivative or analogue of tetracycline, or a chemically modified tetracycline (CMT). Oral administration of a CMT is also disclosed as part of the method for treating meibomian gland disease, ocular irritation associated with delayed tear clearance, or recurrent corneal epithelial erosion.
Methods For Treating Ocular Rosacea
US Patent:
2006015, Jul 13, 2006
Filed:
Dec 7, 2005
Appl. No.:
11/297780
Inventors:
Stephen Pflugfelder - Miami FL, US
Balakrishna Lokeshwar - Miami FL, US
Marie Selzer - Fort Lauderdale FL, US
Balakrishna Lokeshwar - Miami FL, US
Marie Selzer - Fort Lauderdale FL, US
International Classification:
A61K 31/65
US Classification:
514152000
Abstract:
A method for treating a patient having meibomian gland disease, ocular irritation associated with delayed tear clearance, or recurrent corneal epithelial erosion, is disclosed. Preferably, the method concerns treatment of a patient with topical tetracycline, a derivative or analogue of tetracycline, or a chemically modified tetracycline (CMT). Oral administration of a CMT is also disclosed as part of the method for treating meibomian gland disease, ocular irritation associated with delayed tear clearance, or recurrent corneal epithelial erosion.
Method For Treating Meibomian Gland Disease
US Patent:
2011003, Feb 17, 2011
Filed:
Jul 21, 2010
Appl. No.:
12/841058
Inventors:
Stephen C. Pflugfelder - Miami FL, US
Balakrishna L. Lokeshwar - Miami FL, US
Marie Selzer - Fort Lauderdale FL, US
Balakrishna L. Lokeshwar - Miami FL, US
Marie Selzer - Fort Lauderdale FL, US
Assignee:
The University of Miami - Miami FL
International Classification:
A61K 31/65, A61P 27/02
US Classification:
514152
Abstract:
A method for treating a patient having meibomian gland disease, ocular irritation associated with delayed tear clearance, or recurrent corneal epithelial erosion, is disclosed. Preferably, the method concerns treatment of a patient with topical tetracycline, a derivative or analogue of tetracycline, or a chemically modified tetracycline (CMT). Oral administration of a CMT is also disclosed as part of the method for treating meibomian gland disease, ocular irritation associated with delayed tear clearance, or recurrent corneal epithelial erosion.
Methods And Compositions For Treating Meibomian Gland Disease
US Patent:
2008021, Sep 4, 2008
Filed:
Oct 11, 2007
Appl. No.:
11/974435
Inventors:
Stephen C. PFLUGFELDER - Miami FL, US
Balakrishna L. LOKESHWAR - Miami FL, US
Marie SELZER - Fort Lauderdale FL, US
Balakrishna L. LOKESHWAR - Miami FL, US
Marie SELZER - Fort Lauderdale FL, US
International Classification:
A61K 31/165, A61P 27/02
US Classification:
514152
Abstract:
A method for treating a patient having meibomian gland disease, ocular irritation associated with delayed tear clearance, or recurrent corneal epithelial erosion, is disclosed. Preferably, the method concerns treatment of a patient with topical tetracycline, a derivative or analogue of tetracycline, or a chemically modified tetracycline (CMT). Oral administration of a CMT is also disclosed as part of the method for treating meibomian gland disease, ocular irritation associated with delayed tear clearance, or recurrent corneal epithelial erosion.